Annual CFF:
$1.01B+$621.49M(+159.79%)Summary
- As of today, CRNX annual cash from financing is $1.01 billion, with the most recent change of +$621.49 million (+159.79%) on December 31, 2024.
- During the last 3 years, CRNX annual cash from financing has risen by +$757.76 million (+299.89%).
- CRNX annual cash from financing is now at all-time high.
Performance
CRNX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$3.08M-$3.97M(-56.29%)Summary
- As of today, CRNX quarterly cash from financing is $3.08 million, with the most recent change of -$3.97 million (-56.29%) on September 30, 2025.
- Over the past year, CRNX quarterly cash from financing has dropped by -$54.24 million (-94.62%).
- CRNX quarterly cash from financing is now -99.44% below its all-time high of $554.04 million, reached on December 31, 2024.
Performance
CRNX Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$568.61M-$54.24M(-8.71%)Summary
- As of today, CRNX TTM cash from financing is $568.61 million, with the most recent change of -$54.24 million (-8.71%) on September 30, 2025.
- Over the past year, CRNX TTM cash from financing has increased by +$74.29 million (+15.03%).
- CRNX TTM cash from financing is now -43.73% below its all-time high of $1.01 billion, reached on December 31, 2024.
Performance
CRNX TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CRNX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +159.8% | -94.6% | +15.0% |
| 3Y3 Years | +299.9% | +186.6% | +99.0% |
| 5Y5 Years | +10000.0% | +2051.9% | +396.6% |
CRNX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +728.5% | -99.4% | +2581.7% | -43.7% | +3867.2% |
| 5Y | 5-Year | at high | >+9999.0% | -99.4% | +2051.9% | -43.7% | +3867.2% |
| All-Time | All-Time | at high | >+9999.0% | -99.4% | +701.2% | -43.7% | >+9999.0% |
CRNX Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $3.08M(-56.3%) | $568.61M(-8.7%) |
| Jun 2025 | - | $7.05M(+59.0%) | $622.86M(+0.3%) |
| Mar 2025 | - | $4.44M(-99.2%) | $621.30M(-38.5%) |
| Dec 2024 | $1.01B(+159.8%) | $554.04M(+866.5%) | $1.01B(+104.4%) |
| Sep 2024 | - | $57.33M(+943.1%) | $494.32M(-36.2%) |
| Jun 2024 | - | $5.50M(-98.6%) | $774.87M(-0.9%) |
| Mar 2024 | - | $393.57M(+937.8%) | $782.03M(+101.1%) |
| Dec 2023 | $388.94M(+218.9%) | $37.92M(-88.8%) | $388.94M(+10.8%) |
| Sep 2023 | - | $337.88M(+2569.3%) | $351.13M(+2349.8%) |
| Jun 2023 | - | $12.66M(+2515.3%) | $14.33M(-88.1%) |
| Mar 2023 | - | $484.00K(+320.9%) | $120.67M(-1.1%) |
| Dec 2022 | $121.96M(-51.7%) | $115.00K(-89.3%) | $121.96M(-57.3%) |
| Sep 2022 | - | $1.08M(-99.1%) | $285.70M(-4.8%) |
| Jun 2022 | - | $118.99M(+6584.9%) | $300.09M(+18.0%) |
| Mar 2022 | - | $1.78M(-98.9%) | $254.40M(+0.7%) |
| Dec 2021 | $252.68M | $163.86M(+959.7%) | $252.68M(+184.2%) |
| Sep 2021 | - | $15.46M(-78.9%) | $88.92M(+21.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $73.30M(>+9900.0%) | $73.30M(-32.2%) |
| Mar 2021 | - | $57.00K(-41.2%) | $108.15M(-5.6%) |
| Dec 2020 | $114.57M(>+9900.0%) | $97.00K(+161.4%) | $114.57M(+0.1%) |
| Sep 2020 | - | -$158.00K(-100.1%) | $114.49M(-0.2%) |
| Jun 2020 | - | $108.15M(+1568.5%) | $114.67M(+1656.3%) |
| Mar 2020 | - | $6.48M(>+9900.0%) | $6.53M(+9644.8%) |
| Dec 2019 | $67.00K(-100.0%) | $17.00K(-22.7%) | $67.00K(+13.6%) |
| Sep 2019 | - | $22.00K(+175.0%) | $59.00K(-99.9%) |
| Jun 2019 | - | $8000.00(-60.0%) | $107.23M(+0.5%) |
| Mar 2019 | - | $20.00K(+122.2%) | $106.71M(-37.3%) |
| Dec 2018 | $170.20M(+1339.6%) | $9000.00(-100.0%) | $170.20M(-4.0%) |
| Sep 2018 | - | $107.19M(>+9900.0%) | $177.26M(+153.0%) |
| Jun 2018 | - | -$513.00K(-100.8%) | $70.06M(-0.7%) |
| Mar 2018 | - | $63.51M(+798.2%) | $70.57M(+892.3%) |
| Dec 2017 | $11.82M(>+9900.0%) | $7.07M(>+9900.0%) | $7.11M(>+9900.0%) |
| Sep 2017 | - | -$10.00K(-119.6%) | $41.00K(-19.6%) |
| Mar 2017 | - | $51.00K | $51.00K |
| Dec 2016 | -$53.00K | - | - |
FAQ
- What is Crinetics Pharmaceuticals, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. annual cash from financing year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
What is Crinetics Pharmaceuticals, Inc. annual cash from financing?
The current annual cash from financing of CRNX is $1.01B
What is the all-time high annual cash from financing for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high annual cash from financing is $1.01B
What is Crinetics Pharmaceuticals, Inc. annual cash from financing year-on-year change?
Over the past year, CRNX annual cash from financing has changed by +$621.49M (+159.79%)
What is Crinetics Pharmaceuticals, Inc. quarterly cash from financing?
The current quarterly cash from financing of CRNX is $3.08M
What is the all-time high quarterly cash from financing for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high quarterly cash from financing is $554.04M
What is Crinetics Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
Over the past year, CRNX quarterly cash from financing has changed by -$54.24M (-94.62%)
What is Crinetics Pharmaceuticals, Inc. TTM cash from financing?
The current TTM cash from financing of CRNX is $568.61M
What is the all-time high TTM cash from financing for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high TTM cash from financing is $1.01B
What is Crinetics Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
Over the past year, CRNX TTM cash from financing has changed by +$74.29M (+15.03%)